Sumatriptan Succinate

Medication for migraine

key word:

migraine Medication

Category:

API

Related

Product Description

Integrity, innovation, cooperation, sharing, win-win

The company integrates multiple resources and strives to build a δlarge health industry finance platform company integrating pharmaceutiαcal, intelligent medical, bio pharmaceutical R&D, indus♠trial production and sales.

The chemical reactions involved in the existing products include Fouca♦ult reaction, nitration reaction, sulfonation reaction, hy±drogenation reaction, fluorination reaction, chlorination reaction,' bromination reaction, diazotization reaction, format reaction, etc.

Medication for migraine

Related products

Sitagliptin Phosphate Monohydrate

Sitagliptin phosphate is a dipeptidyl peptidase-4 (DPP4) inhibitor devel¥oped by Merck. In October 2006, Sitagliptin phosphate Januvia was approved by FDA as the fir<st DPP4 inhibitor for the treatment of type ⅱ diabetes mellitus. TheΩ characteristics of this drug are that it can stimulate insulin secretion while reduc↔ing hunger without causing weight gain. Hypoglycemia a nd edema will not occur, and it is suitable for dia♠betic patients with poor blood glucose control and frequent hypoglycemia.

Sumatriptan Succinate

Medication for migraine

Vildagliptin

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical en✘terprise that is market-oriented and realizes industrial development through R&D innovation and te♦chnology transformation.

Ketoprofen

The non-steroidal anti-inflammatory drug ketoprofen is on₩e of the most important products for the treatment of arthritis. It is well tolerated and> has a low incidence of side effects

Pranlukast

Pranlukast, developed by Ono, is one of the three ma∑jor leukotriene receptor antagonists. In clinical application, it has go™od therapeutic effect on atopic asthma and other types of bronchial asthma, and the market prospeγct is huge. In the major category of asthma drugs, leukotr∑iene receptor antagonists have the fastest growing market share.

Avanafil

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is market-orie✘nted and realizes industrial development through R&D innovation and technology transf<ormation.

Donepezil HCL

Treatment of mild to moderate Alzheimer's syndrome. It is÷ the second drug approved by FDA for Alzheimer's dis ease in the United States. Its treatment reaches the target d<ose and has low toxic and side effects. It has been widely recognized by our medical♣ community, and good tolerance is its biggest advantage. In¶ October 1999, Donepezil was launched in China under the trade ↔name "Aricept", which is the main chemical drug against Alz÷heimer's disease. At present, CFDA has approved a number of d$omestic enterprises to produce donepezil preparations, the main dosage forms are ta​blets, capsules, dispersive tablets, oral disintegrating tablets.

Almotriptan

Migraine medication for adolescents

Apixaban

English name Apixaban Trade name ELIQUIS, tablet: Apixaban (Eliquis, Bristol-Myers Squibb/Pfizer),  a direct oral factor Xa inhibitor, was approved for use in the 27 EU member states. The →world's first drug approved to prevent venous thro×mboembolism (VTE) in adult patients undergoing elective hip or knee replacement. From June 2019 t"o June 2020, the annual sales of apixaban products overseas reac₽hed about $15.4 billion, with a year-on-year growth of nearly 32%, and the API cons₽umption reached about 23,960 kg, with a year-on-year growth of€ about 28%. Compared with its main competitor, Rivaroxaban, the drug's annual overseas sales are ab♣out $4.5 billion higher.

Lenvatinib

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is market-o≈riented and realizes industrial development through R&D innovation and technology transformationλ.

Clofarabine

It is a nucleotide analogue developed by Bioenvision and manufactureΩd by Genzyme. On December 29, 2004, it was approved by FDA for the treatment of refra→ctory or relapsed acute lymphoblastic leukemia (ALL) in child±ren.

Upadacitinib(Scientific research)

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is market-orient ed and realizes industrial development through R&D innovation and technolφogy transformation.

Product Consulting

Our staff will contact you within 24 hours (workin g days). If you need other services, E-mail: 2880705932@qq.com
Submit

Copyright © 2022 Anhui Union Pharmaceuticals Technology Co., Ltd.